What is Alibaba Health Information Technology Limited?
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong.
ALBHF · Verdict
Solid reward · moderate risk
ALBHF stands out on growth and balance sheet, but watch the volatility signal.
Based on 88% data coverage
ALBHF · Verdict
Revenue +14.1% CAGR
Interest covered 598.9×
P/E 18.5× · PEG 0.66
Weak vs peers
5% net margin · 12% ROE
Model-based scoring. For information only — not financial advice.
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 11.61B, and a P/E ratio of 36.0x.
The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.